Now showing items 1-1 of 1
The Clinical Utility of Y-PSMA2 Monoclonal Antibody in the Detection of Primary and Peripheral Blood Metastatic Prostate Cancer
(Pluto Journals, 2006)
The monoclonal antibody 7E11-C5.3 was the first anti-PSMA antibody to be developed. It recognizes a PSMA intracellular epitope, is radio-labeled and used to detect early recurrent and metastatic prostate cancer. The ...